Autologous vein lined and vein covered stents in swine arteries. An experimental study to assess and compare patency and intimal hyperplastic response

Journal of Cardiovascular Surgery

Volumn 39, Issue 4, 1998, Pages 393-398

  Byer, A ^a,c   Ussia, G ^b   Galleti, G ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Disease models, animal; Stents; Tunica intima surgery

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOTOMY; ARTERY GRAFT; ARTERY OCCLUSION; ARTICLE; AUTOTRANSPLANTATION; BLOOD VESSEL GRAFT; BRAIN; CAROTID ARTERY; DOPPLER ECHOGRAPHY; GRAFT SURVIVAL; HYPERPLASIA; ILIAC ARTERY; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; STENT; SWINE; THROMBOGENICITY; VASCULAR ENDOTHELIUM; VEIN GRAFT;

ANIMALS; CAROTID ARTERIES; FOREIGN-BODY MIGRATION; HYPERPLASIA; ILIAC ARTERY; STENTS; SWINE; TUNICA INTIMA; VASCULAR PATENCY; VEINS;

EID: 0031728846     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mata LA, Bosch X, David PR, Rapold HJ, Corcos T, Bourassa MG. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol 1985;6:1239-44.
2. Holmes DR, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984;53:77-81C.
3. Guiteras Vali P, Bourbassa MG, David PR, Bonan, R, Crepeau J, Dyrda I et al. Restenosis after successful percutaneous transluminal coronary angioplasty: The Montreal Heart Institute experience. Am J Cardiol 1987;60:50-8.
4. Austin GE, Ratliff NH, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-75.
5. White CS, Knudson M, Schmidt D, Chisholm RJ, Vandormael M, Morton B et al. Neither ticlopidine nor aspirin-dipyridamole prevents restenosis post-PTCA: results from a randomized placebo-controlled multicenter trial (abstr). Circulation 1987;76(suppl IV):IV-213.
6. Schwartz L, Bourassa MG, Lesperance J, Aldridge, HE, Kazim F, Salvatori VA et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-9.
7. Ellis SG, Roubin GS, Wilentz J, Lin S, Douglas JS Jr, King SB III. Results of a randomized trial of heparin and aspirin vs aspirin alone for prevention of acute closure (AC) and restenosis after angioplasty (PTCA) (abstract). Circulation 1987;76(suppl V):IV-213.
8. Thornton MA, Gruntzig AR, Hollman J, King SB, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 1984;69:721-7.
9. Ellis SG, Roubin GS, Wilentz J, Douglas JS, King SB. Effect of 18-24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989;117:777-82.
10. Corcus T, David PR, Val PG, Renkin, J, Dangoisse V, Rapold HG et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:926-31.
11. Whitworth HB, Roubin GS, Hollman J, Meier B, Leimgruber PP, Douglas JS Jr et al. Effect of nifedipine on recurrent restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-6.
12. Dehmer GJ, Popma JJ, Van Den Berg FK, Eichhorn EJ, Prewitt JB, Campbell WB et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988;319:733-40.
13. Califf RM, Ohman EM, Frid DJ. Restenosis: the clinical issues. In: Topol EJ, editor. Textbook of interventional cardiology. Philadelphia: WB Saunders, 1989:363-94.
14. Sigwart U, Puel J, Mirkovitch V, Joffre K, Kappenbergery L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-6.
15. Serruys PW, Dejaegere P, Kiemeneij F, Macaya C, Rutsch W, Hendrickx G. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with CA disease. N Engl J Med 1994;331:484-95.
16. Schatz RA, Palmaz JG, Tio FO, Garcia F, Garcia O, Reuter SR. Balloon expandable intracoronary stents in the adult dog. Circ Res 1987;76:450-7.
17. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent II Pilot study. Circulation 1996(33):412-22.
18. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetycholine. Nature 1980;228:373-6.
19. Dusting GJ, Vane JR. Some cardiovascular properties of prostacyclin (PGI-2) which are not shared by PGE 2. Circ Res 1980;46 (suppl I):183-7.
20. Cocks TM, Angus AR. Endothelium dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 1983;305: 627-30.
21. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986;8:344-8.
22. Zvonimir SK, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989;257: H33-7.
23. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
24. Jayakody L, Senaratne M, Thomson A, Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res 1987;60:251-64.
25. Frieman PC, Mitchell GC, Heistad DD, Armstrong ML, Harrison DG. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 1986;58:783-9.
26. Wilson SE, Sheppard B. Results of percutaneous transluminal angioplasty for peripheral vascular occlusive disease. Ann Vasc Surg 1990;44-97.
27. Batayias GE, Korns ME, Pintar K. The spectrum of pathologic changes in aortocoronary saphenous vein grafts. Circulation 1977;56(suppl II):18.
28. Abbott WM, Weiland S, Austen WG. Structural changes during preparation of autogenous venous grafts. Surgery 1974;76:1031-40.
29. Morinaga K, Eguchi H, Miyazaki T, Okadome K, Sugimachi K. Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs. J Vasc Surg 1987;5:719-30.
30. Wyatt AP, Rothnie NG, Raylor GW. The vascularization of vein grafts. Br J Surg 1964;51:378-81.
31. Bandyk DF, Kaebnick HW, Stewart GW, Towne JB. Durability of the in situ saphenous vein arterial bypass: A comparison of primary and secondary patency. J Vasc Surg 1987;5:256-68.
32. Byer A, Moss CM, Keys RC, Hobson R, Padberg F, Campion T. Reverse tapered versus straight PTFE grafts in dogs. J Cardiovasc Surg 1988;29:6.470-5.
33. Stefanidis C, Vlachopoulos C, Kallikazaros P. Autologous vein graft coating applied to vascular stents: The ideal ocated stent? Eur Heart J. 1994;15(Suppl):532.
34. Leon MB, Wong SC. Intracoronary stents, a breakthrough technology or just another small step. Circulation 1994;89(3):1323-7.